Jenny Yang

Head of External Innovation, APAC at Novo Nordisk

Speaker

Dr. Jenny Yang is a senior biopharma executive, scientist, inventor, and recognized leader in biopharma innovation and strategic partnerships, with over 25 years of experience spanning scientific research, biopharmaceutical development, technology innovation, and business strategy.

She serves as Head of External Innovation, Asia Pacific at Novo Nordisk, where she leads the identification, evaluation, and advancement of high-impact biopharma opportunities across the region. Working at the intersection of science, innovation, and business, she partners with biotech entrepreneurs, investors, academic innovators, and industry leaders to accelerate the translation of breakthrough discoveries into transformative healthcare solutions.

Previously, Jenny served as Vice President and Head of Discovery Technology China at Novo Nordisk, where she built and scaled a leading discovery organization and contributed to more than 50 pipeline programs. She is also a co-inventor of Mim8 (denecimig), an innovative bispecific antibody for haemophilia.

Jenny holds a BS from Peking University, a PhD from Columbia University, completed post-doctoral training at Caltech as a Howard Hughes Medical Institute (HHMI) Fellow, and earned an MBA from the University of Chicago Booth School of Business. A frequent speaker at international conferences, she is passionate about advancing innovation ecosys-tems and strategic partnerships that bring new medicines to patients worldwide.